Conference
Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG)
Authors
Wells JC; Sidhu A; Ding K; Heng DYC; Shepherd F; Ellis PM; Bradbury PA; Jonker DJ; Moore M; Siu LL
Volume
30
Pagination
pp. 720-720
Publisher
ELSEVIER
Publication Date
October 1, 2019
Name of conference
44th Annual Congress of the European-Society-for-Medical-Oncology (ESMO)
Conference place
SPAIN, Barcelona
Conference start date
September 27, 2019
Conference end date
October 1, 2019
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534